Author

Dennis A. Romero

ORCID 0000-0002-8222-5574Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:bacteria (other)· 2 Approach:comparative / phylogenetic analysis· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Anne M. Millen· 2 shared Audrey LeprinceiD· 2 shared Damian MagilliD· 2 shared Geneviève M. RousseauiD· 2 shared Justine Lefrançois· 2 shared Philippe HorvathiD· 2 shared Sylvain MoineauiD· 2 shared Vincent SomervilleiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Anne M. Millen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintOct 5, 2026

Uncovering novel phage defense systems through genomic island analysis in Streptococcus thermophilus

Audrey Leprince, Vincent Somerville, Justine Lefrançois…·Sylvain Moineau

This study identifies novel antiviral defense systems in Streptococcus thermophilus by analyzing genomic islands, revealing previously uncharacterized systems and highlighting their role as reservoirs of bacterial immunity.

DOI 10.64898/2026.10.04.756616

bacteria (other)whole-genome sequencing

𝕏 PostBluesky

MicrobiologyNature CommunicationsPeer-reviewedAug 4, 2025

Strengthening Phage Resistance of Streptococcus thermophilus by Leveraging Complementary Defense Systems

Audrey Leprince, Justine Lefrançois, Anne M. Millen…·Sylvain Moineau

This study identifies and validates 21 accessory defense systems in S. thermophilus, showing that some provide stronger phage resistance than CRISPR-Cas, especially when combined or expressed from plasmids.

15 citationstop 2%

bacteria (other)experimental assay

𝕏 PostBluesky